Berlin: BioNTech expects results by September from trials testing the COVID-19 vaccine that it and Pfizer have developed in babies as young as six months...
New Delhi: The phase 1 clinical trial findings of Bharat Biotech’s COVID-19 vaccine ‘COVAXIN’ has revealed no serious adverse effects, said the interim report. Around...